Private, no accountPrivacy details: browsing privately, no account needed
You're browsing privately, no account needed. Your region stays in this session and your precise location is never stored.What we store
H.R. 8553 · 116th CongressIn committee

Managing American Knowledge and Equipment to Prevent Pandemic Emergencies Act

Latest action. Referred to the subcommitteeA smaller panel inside a standing committee with jurisdiction over a slice of its subject matter. Most hearings and the first markup usually happen here.Read the full definition (opens a new tab) on Economic Development, Public Buildings, and Emergency Management. · October 13, 2020

Live record from Congress.gov, updated as the official record changes.
What this bill would do
Official summary · Congressional Research Service

Managing American Knowledge and Equipment to Prevent Pandemic Emergencies Act or the MAKE PPE Act

This bill addresses federal planning and coordination related to production and distribution of personal protective equipment and other critical nonpharmaceutical supplies during public health emergencies. It also supports efforts to expand domestic manufacturing and production of the materials and incorporates inventory management of the materials in existing grants for community and hospital preparedness.

The bill specifically directs the Federal Emergency Management Agency (FEMA) to develop the capacity to coordinate these activities. In addition, FEMA, the Executive Office of the President, and the Department of Health and Human Services must jointly develop, in consultation with relevant federal partners, a protocol for federal procurement and distribution of equipment and supplies during emergencies. They must report to Congress on this protocol.

FEMA must also establish the Office of Pandemic Preparedness and Response to coordinate, and develop a strategy related to, the procurement and distribution of critical materials. Among other tasks, the office must set up a data repository to track the demand for these materials.

With respect to expanding domestic production, the Department of Defense and the Department of Veterans Affairs must, subject to some exceptions and waivers, purchase critical nonpharmaceutical materials that are produced domestically. Additionally, the National Institutes of Standards and Technology must award grants for U.S. manufacturers to expand domestic production capacity of critical materials and for entities to develop educational materials to aid the public in making temporary masks and other equipment.

Written by analysts at the Congressional Research Service and published on Congress.gov, not by Civibrief. Summarized at the "Introduced in House" stage on October 9, 2020. It describes the bill, it is not the legal text.

Status
Introduced
October 9, 2020
In committee
October 13, 2020
Passed a chamber
Cleared Congress
Enacted
Where this sits in the process
Common questions
Composed from the official record
Where is it in the process, and what happens next?

4 steps remain before this bill could become law.

The record's latest action, on October 13, 2020: Referred to the Subcommittee on Economic Development, Public Buildings, and Emergency Management.

  1. Clearing the committees it was referred to, and being scheduled for a floor vote
  2. Passage by the House
  3. Passage by the Senate
  4. The President's signature. If the President vetoes it, two-thirds of both chambers must vote to override.
How likely is it to become law?

Civibrief does not forecast outcomes and this page has no opinion about this one. What the record supports is a base rate, which is a fact about the whole pile, not a prediction about this measure.

In the 116th Congress (2019-20), 344 of the 14,345 bills and joint resolutions introduced became law, about 2.4 percent. That count covers every measure at every stage, including the many that never left committee.

This one is not there yet: 4 steps are still outstanding, listed above.

Has anyone actually voted on it?

No. No roll call in this Congress cites this measure. That is the ordinary outcome: most measures never reach a recorded floor vote, and a committee ends most of them simply by not acting.

A vote is not the only thing that happens to a measure. Hearings, markups, and referrals are all recorded actions, and none of them is a vote of the full chamber.

Who is behind it?

Matt Cartwright (D-PA) introduced it on October 9, 2020, and 3 members have since signed on as cosponsors.

They are 3 Democrats.

Cosponsoring is a formal signature on the text. It is not a commitment to vote for the measure, it does not bind anyone's party, and a long list of cosponsors is a measure of attention rather than of prospects.

How long has it been in play?

It was introduced on October 9, 2020, 2209 days ago. The most recent recorded action was 2205 days ago, on October 13, 2020.

Measures do not carry over. Anything the 116th Congress has not finished by January 3, 2021 dies when the term ends, and has to be introduced again from the start in the next Congress.

Every answer above is assembled from this measure's own record on Congress.gov and from published counts of what Congress has passed before. Civibrief does not predict outcomes and takes no position on any measure.

Vote history

  1. House
    In committee, no floor vote yet
  2. Senate
    Awaits House passage
  3. President
    Awaits both chambers
No recorded votes yet
No roll call in this Congress cites this bill. Most bills die in committee without ever reaching a recorded floor vote.